Evaluation of the Role of Interleukin 6 in Paget’s Disease of Bone
Kathryn Berg, Katya Johnson, James F. Wilson, Jonathan C. Y. Tang, Stuart H. Ralston · 2026
Read Evaluation of the Role of Interleukin 6 in Paget’s Disease of Bone by Kathryn Berg, Katya Johnson, James F. Wilson, Jonathan C. Y. Tang, Stuart H. Ralston (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13538248.txt.
Description
Kathryn Berg and co-authors test whether a blood signal called interleukin 6 drives the excess bone breakdown in Paget's disease. Their 2026 study measures the signal in 553 patients from two trials and 533 people without the disease. Earlier reports had found raised levels in some patients, hinting the signal might spur the bone-eating cells behind the disease.
After adjusting for age and kidney function, patients and controls showed no real difference in levels. The signal also failed to track with how many bones were affected or with bodily pain. It did rise mildly alongside two markers of bone formation. The authors conclude that raised blood levels of this signal are unlikely to be a main driver of the disease.
Catalog record
| CREATOR | Kathryn Berg, Katya Johnson, James F. Wilson, Jonathan C. Y. Tang, Stuart H. Ralston |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |